Trials / Completed
CompletedNCT03062787
Early Effect of Cingal® Compared to Monovisc® in Patients With Osteoarthritis of the Knee
Early Effect of Cingal® Compared to Monovisc® in Patients With Osteoarthritis of the Knee (EEFFEK Study)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Pharmascience Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
It is a post-license, multicenter, randomized, single blind, controlled study comparing a single injection of Cingal® (study arm) with a single injection of Monovisc® (control arm).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Cingal® (Hyaluronic Acid plus Triamcinolone Hexacetonide) | Intra-articular injection |
| DEVICE | Monovisc® (Sodium hyaluronate) | Intra-articular injection |
Timeline
- Start date
- 2017-04-05
- Primary completion
- 2017-10-25
- Completion
- 2017-10-25
- First posted
- 2017-02-23
- Last updated
- 2020-04-21
Locations
5 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT03062787. Inclusion in this directory is not an endorsement.